Certified Advisory Corp’s Vertex Pharmaceuticals VRTX Stock Holding History

Certified Advisory Corp’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-90	Closed	-$19K	–	731
2021 Q1	$19K	Buy	+90	New	+$19.8K	﹤0.01%	504
2020 Q2	$34K	Hold	118	–	–	0.01%	356
2020 Q1	$28K	Hold	118	–	–	0.01%	359
2019 Q4	$26K	Hold	118	–	–	0.01%	429
2019 Q3	$20K	Buy	118 +83	+237%	+$14.7K	0.01%	490
2019 Q2	$6K	Hold	35	–	–	﹤0.01%	664
2019 Q1	$6K	Hold	35	–	–	﹤0.01%	621
2018 Q4	$6K	Hold	35	–	–	﹤0.01%	610
2018 Q3	$7K	Hold	35	–	–	﹤0.01%	626
2018 Q2	$6K	Hold	35	–	–	﹤0.01%	619
2018 Q1	$5K	Hold	35	–	–	﹤0.01%	608
2017 Q4	$5K	Buy	+35	New	+$5.18K	﹤0.01%	574

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Certified Advisory Corp's VRTX Position: Q2 2021 in Review

Certified Advisory Corp sold out of Vertex Pharmaceuticals (VRTX) in Q2 2021, closing a stake of 90 shares — an estimated $19K sold.

Certified Advisory Corp first reported a position in VRTX in Q4 2017 and held it in 12 quarters. The position peaked at $34K in Q2 2020. 976 funds tracked by Wall St. Rank hold VRTX as of Q2 2021.

Certified Advisory Corp reported no remaining Vertex Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
Certified Advisory Corp sold 90 Vertex Pharmaceuticals shares in Q2 2021, an estimated $19K.
Certified Advisory Corp first reported a position in Vertex Pharmaceuticals in Q4 2017 and held it in 12 quarters.
Certified Advisory Corp's Vertex Pharmaceuticals position peaked at $34K in Q2 2020.
976 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2021.

Based on Certified Advisory Corp's 13F filing for Q2 2021, filed 16 Aug 2021.